Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN97191554) titled 'Evaluation of the effects of a food supplement in improving acute telogen effluvium in male subjects' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Efficacy
Primary Sponsor: BCF Life Sciences
Condition:
Acute telogen effluvium
Skin and Connective Tissue Diseases
Intervention:
The active supplement consists of a keratin hydrolysate formulation containing Kera-Diet as the active ingredient and rice starch as the excipient, while the placebo contains only maltodextrin.
A restricted ra...